Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.5100
+0.0700 (4.86%)
NASDAQ · Last Trade: Nov 6th, 1:10 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors